Acumen Total Assets from 2010 to 2025

ABOS Stock

USD 1.45 0.01 0.68%

Acumen Pharmaceuticals Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets are likely to outpace its year average in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

356.6 M

Current Value

374.5 M

Quarterly Volatility

141.6 M

Credit Downgrade

Yuan Drop

Covid

Check Acumen Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Acumen Pharmaceuticals' main balance sheet or income statement drivers, such as Net Interest Income of 9.9 M, Interest Income of 9.9 M or Depreciation And Amortization of 157.3 K, as well as many indicators such as Price To Sales Ratio of 415, Dividend Yield of 0.0 or PTB Ratio of 0.66. Acumen financial statements analysis is a perfect complement when working with Acumen Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Acumen Pharmaceuticals Correlation against competitors.

For more information on how to buy Acumen Stock please use our How to Invest in Acumen Pharmaceuticals guide.

Latest Acumen Pharmaceuticals' Total Assets Growth Pattern

Below is the plot of the Total Assets of Acumen Pharmaceuticals over the last few years. Total assets refers to the total amount of Acumen Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Acumen Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Acumen Pharmaceuticals' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Acumen Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 310.12 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Acumen Total Assets Regression Statistics

	Arithmetic Mean	99,113,168
	Geometric Mean	25,730,103
	Coefficient Of Variation	142.84
	Mean Deviation	121,574,481
	Median	7,322,000
	Standard Deviation	141,571,701
	Sample Variance	20042.5T
	Range	367.2M
	R-Value	0.83
	Mean Square Error	6598.9T
	R-Squared	0.69
	Significance	0.000063
	Slope	24,748,972
	Total Sum of Squares	300638.2T

Acumen Total Assets History

	2025	374.5 M
	2024	356.6 M
	2023	310.1 M
	2022	196.6 M
	2021	230.3 M
	2020	44.4 M

Other Fundumenentals of Acumen Pharmaceuticals

Intangibles To Total Assets

Acumen Pharmaceuticals Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Capital Surpluse	Short Term Debt	Common Stock	Property Plant Equipment	Long Term Debt
Total Assets		0.99	0.96	-0.55	-0.97	0.91	0.79	0.2	1.0	0.94	0.94	0.78	0.88	0.8	0.83	-0.7
Total Stockholder Equity	0.99		0.98	-0.6	-0.98	0.92	0.73	0.1	1.0	0.95	0.95	0.75	0.84	0.77	0.83	-0.67
Net Tangible Assets	0.96	0.98		-0.72	-0.96	0.94	0.6	0.0	0.97	0.95	0.95	0.66	0.73	0.66	0.79	-0.58
Net Debt	-0.55	-0.6	-0.72		0.61	-0.75	0.0	0.16	-0.56	-0.66	-0.67	-0.13	-0.1	-0.08	-0.45	0.06
Retained Earnings	-0.97	-0.98	-0.96	0.61		-0.96	-0.72	-0.17	-0.98	-0.96	-0.96	-0.69	-0.83	-0.78	-0.91	0.57
Accounts Payable	0.91	0.92	0.94	-0.75	-0.96		0.58	0.17	0.91	0.97	0.97	0.64	0.68	0.69	0.91	-0.43
Net Receivables	0.79	0.73	0.6	0.0	-0.72	0.58		0.59	0.76	0.65	0.64	0.82	0.97	0.89	0.69	-0.78
Total Liab	0.2	0.1	0.0	0.16	-0.17	0.17	0.59		0.13	0.21	0.2	0.26	0.38	0.46	0.25	-0.12
Net Invested Capital	1.0	1.0	0.97	-0.56	-0.98	0.91	0.76	0.13		0.94	0.94	0.76	0.87	0.79	0.83	-0.69
Total Current Assets	0.94	0.95	0.95	-0.66	-0.96	0.97	0.65	0.21	0.94		1.0	0.68	0.75	0.79	0.87	-0.44
Net Working Capital	0.94	0.95	0.95	-0.67	-0.96	0.97	0.64	0.2	0.94	1.0		0.67	0.74	0.78	0.87	-0.44
Capital Surpluse	0.78	0.75	0.66	-0.13	-0.69	0.64	0.82	0.26	0.76	0.68	0.67		0.86	0.84	0.72	-0.83
Short Term Debt	0.88	0.84	0.73	-0.1	-0.83	0.68	0.97	0.38	0.87	0.75	0.74	0.86		0.92	0.78	-0.8
Common Stock	0.8	0.77	0.66	-0.08	-0.78	0.69	0.89	0.46	0.79	0.79	0.78	0.84	0.92		0.82	-0.57
Property Plant Equipment	0.83	0.83	0.79	-0.45	-0.91	0.91	0.69	0.25	0.83	0.87	0.87	0.72	0.78	0.82		-0.46
Long Term Debt	-0.7	-0.67	-0.58	0.06	0.57	-0.43	-0.78	-0.12	-0.69	-0.44	-0.44	-0.83	-0.8	-0.57	-0.46

Click cells to compare fundamentals

About Acumen Pharmaceuticals Financial Statements

Acumen Pharmaceuticals shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Acumen Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Acumen Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Acumen Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	356.6 M	374.5 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Acumen Stock Analysis

When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC